Back
Phathom Pharmaceuticals Stock Price Chart
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Buy
64
PHAT
Phathom Pharmaceuticals
Last Price:
9.95
Seasonality Move:
-5.3%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Phathom Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.23 | Buy |
| 20-day SMA: | 9.89 | Sell |
| 50-day SMA: | 9.79 | Sell |
| 200-day SMA: | 10.04 | Sell |
| 8-day EMA: | 9.38 | Buy |
| 20-day EMA: | 9.58 | Buy |
| 50-day EMA: | 9.49 | Buy |
| 200-day EMA: | 9.7 | Buy |
Phathom Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 51.72 | Buy |
| Chaikin Money Flow: | 605048 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.11 - 10.85) | Sell |
| Bollinger Bands (100): | (7.51 - 10.23) | Buy |
Phathom Pharmaceuticals Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 9.75 while PHAT 8-day simple moving average is 9.23, which is a Buy signal.
- The stock price of PHAT is 9.75 while Phathom Pharmaceuticals 20-day SMA is 9.89, which makes it a Sell.
- Phathom Pharmaceuticals 50-day simple moving average is 9.79 while PHAT share price is 9.75, making it a Sell technically.
- PHAT stock price is 9.75 and Phathom Pharmaceuticals 200-day simple moving average is 10.04, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Buy
64
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a Buy
The current Phathom Pharmaceuticals [PHAT] share price is $9.75. The Score for PHAT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
570.61M
Price in USD:
9.75
Share Volume:
1.02M
Phathom Pharmaceuticals 52-Week Range
52-Week High:
17.02
52-Week Low:
6.07
Buy
64
Phathom Pharmaceuticals (PHAT)
is a Buy
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?
The Phathom Pharmaceuticals stock price is 9.75 USD today. -
Will PHAT stock go up or go down?
Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Phathom Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is not overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 9.75 while PHAT 8-day exponential moving average is 9.38, which is a Buy signal.
- The stock price of PHAT is 9.75 while Phathom Pharmaceuticals 20-day EMA is 9.58, which makes it a Buy.
- Phathom Pharmaceuticals 50-day exponential moving average is 9.49 while PHAT share price is 9.75, making it a Buy technically.
- PHAT stock price is 9.75 and Phathom Pharmaceuticals 200-day simple moving average is 9.70, creating a Buy signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.75 per share, and an increase next year of $1.24 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
- PHAT Moving Average Covergence Divergence (MACD) indicator is -0.17, suggesting Phathom Pharmaceuticals is a Sell
- Phathom Pharmaceuticals Relative Strength Index (RSI) is 51.72, which suggest Phathom Pharmaceuticals is overbought
- The Bollinger Bands (25) for Phathom Pharmaceuticals is (9.11 - 10.85), which suggest Phathom Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Phathom Pharmaceuticals is (7.51 - 10.23), which suggest Phathom Pharmaceuticals is a Buy
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.